glp-1 coverage medicare New Bridge Program Medicare GLP-1 Bridge Program: $50
Description
Diabetes, Obesity and Metabolism, 26(4), 16-27
Patients taking GLP-1 agonists most commonly complain of gastrointestinal effects, 2 such as unsettled stomach, upset GI tract, variable bowel movements or trouble with elimination, abdominal discomfort, and gastroesophageal discomfort
Only 3% initiated treatment more than 270 days after diagnosis
Our team of experts takes the time to understand your unique needs, health history, and weight loss goals
However, many people mistakenly believe eating as little as possible will enhance their results
